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Abstract
Background—The relation of γ-aminobutyric acid (GABA) to alcohol dependence (AD) has been
widely studied. Several previous studies suggest that GABA may be involved in alcohol withdrawal,
tolerance, and the symptoms that form an AD diagnosis. The genes coding for glutamate
decarboxylase (GAD), the rate-limiting enzyme in GABA synthesis, are of potential interest for their
association to ethanol consumption and AD. There are two isoforms of GAD, GAD1 and GAD2,
which were reported to be associated with AD in males of Han Taiwanese (GAD1) and Russian
(GAD2) ancestry. The present study examined the association of the two GAD isoforms with AD
and relevant alcohol-related traits in the Irish Affected Sib Pair Study of Alcohol Dependence
[Prescott, C.A., Sullivan, P.F., Myers, J.M., Patterson, D.G., Devitt, M., Halberstadt, L.J., Walsh,
D., Kendler, K.S., 2005. The Irish Affected Sib Pair Study of Alcohol Dependence: study
methodology and validation of diagnosis by interview and family history. Alcohol.-Clin. Exp. Res.
29 (3) 417–429].
Methods—Participants were recruited in Ireland, including 575 independent cases who met DSM-
IV AD criteria and 530 controls, screened for heavy drinking. We first conducted case-control
analyses of the GAD genes with AD and, within the cases, examined associations with age at onset
of AD, withdrawal symptoms, and two quantitative measures: initial sensitivity and tolerance (based
on scales from the Self-Rating of the Effects of Ethanol) [Schuckit, M.A., Smith, T.L., Tipp, J.E.,
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1997. The self-rating of the effects of alcohol (SRE) form as a retrospective measure of the risk for
alcoholism. Addiction 92, 979–988]. A total of 29 SNPs were genotyped for GAD1 and GAD2 using
the Illumina GoldenGate protocols. Statistical procedures were implemented to control for false
discovery rates (FDR).
Results—Nine of 29 markers with minor allele frequencies less than 0.01 were removed from
standard analysis; the remaining 20 markers were all in Hardy-Weinberg equilibrium. Three markers
in the intronic regions of GAD1 were associated with initial sensitivity to alcohol (P = 0.002); the
associations remained significant after a FDR based correction for multiple testing. In addition, one
marker located 3 kb upstream of GAD1 exhibited association with age at onset of AD (P = 0.0001).
Gender specific effects were observed in results of both single marker and haplotype analyses.
Conclusion—We found no evidence for the association of GAD genes with AD but significant
association of GAD1 with initial sensitivity and age at onset of AD. Our findings suggest that the
underlying pathophysiology regulated by genes like GAD1 may be more directly related to the
component processes that form AD than to the clinical disorder.
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1. Introduction
In the central nervous system, γ-aminobutyric acid (GABA) is the major inhibitory
neurotransmitter. Results from both human and animal studies suggest that neuroadaptation in
the GABAergic system and pharmacological sensitivity of GABA receptors play important
roles in the behavioral and functional neuronal changes associated with ethanol dependence
(Crabbe et al., 2006; Follesa et al., 2006). Acute ethanol consumption enhances GABA
neurotransmission and inhibits the glutamatergic system (Nevo and Hamon, 1995). The
reduction in excitatory effect and the enhancement of inhibitory GABA neurotransmission
account for the sedating and dose-dependent depressant effects of ethanol intoxication.
However, prolonged ethanol exposure produces neruoadaptation in these neurotransmitter
systems, resulting in reduced inhibitory activity of GABA receptors and a sensitization of N-
methyl-D-aspartic acid receptors (see reviews by Crews et al., 1996; Davis and Wu, 2001).
Sudden cessation of ethanol intake produces a hyperexcitable neuronal state that results in mild
withdrawal symptoms just as the “shakes” which, in more severe cases, leads to seizures,
delirium, and excitotoxic neuronal death (Tsai and Coyle, 1998).
The biosynthesis of GABA largely depends on the enzyme glutamate decarboxylase (GAD)
(Petroff, 2002). Two isoforms of GAD have been identified, GAD1 and GAD2, which
previously were called GAD67 and GAD65, respectively. These enzymes couple with
pyridoxal phosphate as a cofactor and are responsible for catalyzing glutamate to produce
GABA in the brain. In humans, GAD1 maps to chromosome 2q31 and spans about 45 kb, and
GAD2 maps to chromosome 10p11.23 with a size about 88 kb. GAD1 and GAD2 are highly
similar in their catalytic domains, regional expression, and subcellular localization (Erlander
et al., 1991; Feldblum et al., 1995), but are associated with different modes of GABA release.
GAD1 is involved in cytosolic GABA synthesis and is responsible for maintaining basal GABA
levels, whereas GAD2 is predominately involved in synaptosomal GABA release, and can be
rapidly activated when there is high demand for GABA (Soghomonian and Martin, 1998).
Rodent studies suggest that GAD1 is important in maintaining GABA levels in the brain, and
that the GAD1 knockout is usually lethal. In contrast, GAD2 knockout mice maintain normal
brain GABA levels, but are susceptible to seizure, show increased anxiety behavior, and have
decreased response to sedative drugs such as benzodiazepines and pentobarbital (Asada et al.,
1996; Kash et al., 1999).
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Most prior studies of the relation between GAD genes and substance addictive behaviors have
used animal models. Mice and rat studies have shown that GAD genes expression was altered
during diazepam withdrawal (Izzo et al., 2001), alcohol withdrawal or dependence (Eravci et
al., 2000), or chronic exposure to high-dose methamphetamine (Zhang et al., 2006). However,
the evidence of expression alteration of GAD genes is not consistent (Fehr et al., 2003), and
gene expression levels appear to vary by brain region in response to drug treatment. We are
aware of only two published reports examining the association of GAD genes with alcohol-
related phenotypes in humans. Loh et al. (2006) examined the association of 9 SNPs for
GAD1 and 3 SNPs for GAD2 in 140 alcoholic cases and 146 controls in Han Taiwanese men.
They found evidence of association with AD in GAD1 but not GAD2. Lappalainen et al.
(2007) genotyped 13 SNPs for GAD2 in a sample of 113 Russian males with AD and 100
controls and found modest association for a functional marker, rs2236418 (−243 A > G).
However, in the same report, these authors reported they were unable to replicate this
association using two other samples: European–American with AD and U.S. college students
with drinking problems. Therefore, the role of GAD genes in AD and alcohol-related problems
requires further study.
The majority of previous reports, in both animals and humans, included only male subjects.
Gender is an important element when studying substance use. For instance, in humans males
begin drinking regularly and heavily much earlier than females; men also consume larger
amount of alcohol daily than women (Prescott et al., 2005). Although women have a lower
incidence of AD than men, on average, they develop alcohol dependence after a shorter duration
of chronic drinking and show withdrawal following consumption of smaller volumes of
ethanol. Some studies suggest that male and female alcoholics show differences in brain
changes and negative consequences due to alcohol abuse (Pfefferbaum et al., 2001; Wuethrich,
2001). However, lack of genetic association data in female alcoholism is a weakness in the
literature. The first aim of the present study was to test the association of GAD genes with AD
in a different and larger independent sample. Given the differences in the effects of ethanol
between males and females noted above, we tested whether there are gender specific effects
in the association of GAD genes with AD.
In addition, results from quantitative trait locus (QTL) studies in animals suggest that specific
loci may influence different alcohol-related behaviors, such as acute/chronic withdrawal,
preference drinking, and blood level after acute ethanol dose (see Crabbe et al., 1999). One
such alcohol-related trait is the level of response to ethanol, measured by the dose of ethanol
needed to produce a specified effect. Level of response at the time of initial use is a risk factor
for the development of alcoholism (Schuckit and Smith, 2001). Other alcohol-related traits,
including tolerance and withdrawal, reflect physiological adaptation to chronic alcohol use
(Schuckit et al., 1998). Withdrawal is an especially pivotal physical symptom for AD diagnosis
(Langenbucher et al., 2000) and is associated with worse prognosis (Hasin et al., 2000). In
addition to these physiological traits, variation in age at onset of AD may also reflect differences
in the magnitude of the underlying AD liability (Johnson et al., 2000). These quantitative
alcohol-related traits represent different aspects of the dependence process, and may provide
greater insight into the genetic contributions to the risk to develop AD. A second aim of our
study, therefore, was to examine evidence that GAD genes are involved with quantitative
alcohol-related traits including level of response to ethanol, tolerance, withdrawal and age at
onset.
We conducted a genetic association study of both GAD genes in a sample of Western European
origin that is more culturally and genetically homogeneous than samples used in previous
studies. We examine the association of the GAD1 and GAD2 genes with AD and relevant
alcohol-related traits as well as possible gender specific effects in these genetic associations.
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2.1. Subjects and phenotype assessment
Participants in this study were recruited in Ireland and Northern Ireland between 1998 and
2002. Details of the study design, sample ascertainment, and clinical characteristics of this
sample are described elsewhere (Prescott et al., 2005). In brief, ascertainment of probands was
mainly conducted in community alcoholism treatment facilities and public and private
hospitals. Probands were eligible for study inclusion if they met the current DSM-IV criteria
for AD and if all four grandparents had been born in Ireland, Northern Ireland, Scotland, Wales
or England. After a prospective family was identified through probands, parents and potentially
affected siblings whom the probands provided permission to contact were recruited.
Interviews were conducted by clinically trained research interviewers, most of whom had
extensive clinical experience with alcoholism. The interview included demographic
characteristics, lifetime history of AD and alcohol-related traits, and comorbid conditions.
DSM-IV AD was assessed using the SSAGA (Semi-Structured Assessment of the Genetics of
Alcoholism) interview (version II, Bucholz et al., 1994) modified to reduce assessment time
by omitting items that address onset age of each symptom.
All participants provided informed consent. There were 1238 individuals meeting DSM-IV
AD diagnosis from 591 families. Controls were recruited in the Northern Ireland from
volunteers of blood donating (88.5%) and in Ireland from national police force and army
reserve. Controls were screened and their samples excluded if they reported a history of heavy
drinking or problematic alcohol use. In the present case-control study design, we included 530
controls and 575 independent AD cases from the IASPSAD families (for detailed case and
control sample description see Kuo et al., 2008). Samples were selected based on high yield
of high quality DNA for genotyping and only one case per family was included.
In the present study, we are interested in several alcohol-related phenotypes, which are
hypothesized to be associated with GAD genes, including age-at-onset of AD, subjective
response to ethanol, and withdrawal symptoms. Age-at-onset (ONSET) was defined as the age
at which the first criteria for DSM-IV AD was met. Subjective response to ethanol was
measured using the Self-Rating of the Effects of Alcohol, SRE (Schuckit et al., 1997) to form
two scores, initial sensitivity (ISENS) and tolerance/maximum drinking (TOLMX). The SRE
asks how many drinks were required for an individual to experience effects (e.g. feel dizzy,
begin stumbling, or pass out) from alcohol consumption at different stages of alcohol use.
ISENS is based on “the first 5 times you ever drank” and items contributing to TOLMX concern
the “period when you drank the most”. The score of each measure was computed by summing
the number of drinks required to produce an effect and dividing by the numbers of effects
endorsed. The SRE has been shown to have good internal consistency and test–retest reliability,
provide good validity for identifying people who had low response to alcohol in a laboratory
challenge test, and has been associated with AD diagnosis in several populations. A withdrawal
severity factor score (WDSFS) was based on ten symptoms in the SSAGA interview (such as
hands trembling, feeling anxious following cessation or reduction of drinking). To account for
the possible non-equal contribution of each symptom to withdrawal severity, a factor analysis
was conducted (for details see Kuo et al., 2006). A factor score of withdrawal severity for each
individual was derived based on the item loadings on one major factor, which accounted for
70% of the variance in these symptoms based on the entire IASPSAD sample.
2.2. Genotyping
Genotypes for a total of 29 SNPs in the GAD1 (N = 12) and GAD2 (N = 17) genes were obtained
as part of a large candidate gene study using an Illumina custom genotyping array designed in
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Dr. David Goldman's Laboratory of Neurogenetics, National Institute on Alcohol Abuse and
Alcoholism. Detailed information of array design, genotyping and SNP selection are described
elsewhere (Hodgkinson et al., 2008). In brief, for each gene selected, a genomic region
including 5 kb upstream and 1 kb downstream was retrieved from NCBI Human Genome Build
35.1 and minimum index SNPs that represented maximum haplotype information for each gene
were selected. The performance of the initially selected SNP set was validated by the
manufacturer and replacements made where necessary. None of the selected 12 SNPs in
GAD1 are coding SNPs, and two of them are at 5′ of the gene (around 1 kb and 3 kb upstream,
respectively). One selected SNP in GAD2 is a coding SNP (rs2839673, locates in exon 6; A/
G polymorphism codes for Glu/Gly) with a low minor allele frequency (0.01) in the present
sample.
All genotyping was conducted in Dr. David Goldman's Laboratory. Genotyping was performed
using the Illumina GoldenGate genotyping protocols on 96-well format Sentrix® arrays and
500 ng of sample DNA were used per assay. All pre-PCR processing was performed using a
TECAN liquid handling robot running Illumina protocols. Arrays were imaged using an
Illumina Beadstation GX500 and the data analyzed using GenCall v6.2.0.4 and GTS Reports
software v5.1.2.0 (Illumina).
2.3. Statistical methods
Case-control association analyses for AD were conducted using PLINK (Purcell,
http://pngu.mgh.harvard.edu/∼purcell/plink/) at both single marker and haplotype levels for
GAD1 and GAD2 genes. For quantitative alcohol-related traits measured within the cases, we
used regression based models implemented in PLINK to calculate effect size and significance
level for each marker. To examine the gender specific effects in the association of GAD genes
with AD and alcohol-related traits, the aforementioned case-control binary and case-only
quantitative association analyses were conducted in the overall sample and in the female and
male samples separately. Among 1105 total samples, there were 668 males (370 cases), 433
females (204 cases), and 4 samples with unspecified sex1 which were excluded from gender
specific analysis.
To address multiple testing issues in these analyses, a FDR (false discovery rate) based
procedure (Benjamini and Hochberg, 1995) was implemented using the SAS package to obtain
adjusted P-values. The FDR is estimated as the proportion of expected false rejections over
the total number of rejections and is determined from the observed P-value distribution.
Haploview 4.0 was used to calculate the strength of linkage disequilibrium (LD, i.e. the non-
random association of alleles at two or more loci) using the D′ index. Relative location of SNPs
within each GAD gene and the LD plot are shown in Fig. 1 (detailed information of both D′
and r2 indexes of pair-wise SNPs for each GAD gene is listed in supplement Table 1). Haplotype
blocks were defined using the default method in Haploview by Gabriel et al. (2002). In general,
there was high LD within each GAD gene.
3. Results
Summary information of alcohol-related traits and comorbid major depressive disorder by
gender is shown in Table 1. In general, men exhibited more severe alcohol-related problems
compared to women. Men had younger age-at-onset of AD, drank more to feel the effects of
ethanol during both early exposures and the period of heaviest drinking and had more
1Most of the controls were obtained from blood donation centers and the sex of the donors was not available to us directly. Therefore,
the sex of subjects was determined experimentally by genotyping 3 X-specific and 3 Y-specific SNPs. We cannot determine sex of four
subjects either due to failure of genotyping or the genotyping results were not conclusive.
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withdrawal symptoms than women (detailed description of alcohol-related behaviors for the
whole IASPSAD family sample is in Prescott et al., 2005).
3.1. Genotyping completion
Genotyping was completed for 12 SNPs in GAD1 and 17 SNPs in GAD2. Among the 29
genotyped SNPs we excluded 1 with a low genotyping rate (<80%) and 8 with MAF < 0.01,
leaving 9 in GAD1 and 11 in GAD2. The average genotyping call rate for these 20 SNPs
analyzed was ranged from 94.3 to 95.5%. All SNPs retained in the analysis were in Hardy-
Weinberg equilibrium (using a cutoff P-value of 0.001) in the overall sample and in controls
alone. Among the 1105 genotyped individuals, 16 (9 cases, 7 controls) were removed from
analysis because of genotyping call rates less than 50%. The sample included in the final
analysis thus consisted of 566 AD cases and 523 controls. The average genotyping rate among
these individuals is 95.84%.
3.2. Single marker association
Marker information, allele frequency and single marker allelic association results are displayed
in Table 2 for 20 SNPs in the two GAD genes. In the total sample, no SNP in either GAD gene
was associated with AD (other than allelic association test, genotypic tests including general
genotype test, dominant & recessive models, and Cochran-Armitage trend test were also
performed. No genotypic associations were found and results were not presented in Table 2).
Among females, several SNPs in GAD2 showed modest association (P = 0.04) with AD,
although the effects become non-significant after adjusting for false discoveries (Table 2).
Quantitative association results of single markers for each alcohol-related trait are listed in
Table 3. A positive regression coefficient in the regression models indicates that individuals
with the minor allele have higher scores for the examined trait, and vice versa. For instance,
the negative value (−1.24) for ONSET in the total sample at the first marker listed (rs1978340)
indicates that individuals with the minor allele of rs1978340 have earlier AD onset than those
with the common allele. This association of marker rs1978340 with ONSET exhibits a strong
effect (regression coefficient = −2.28 with a FDR adjusted P < 0.001) in male samples. Three
other markers in GAD1 showed association with ISENS in the total sample (FDR adjusted P
= 0.015). These three markers showed modest association in male subgroup, but were not
significant after adjusting for false discoveries. The negative regression coefficients of the three
markers with ISENS indicate higher response to ethanol (lower number of drinks needed to
feel subjective effects) with the minor allele, which suggests that a common allele of these
markers may increase the risk for developing AD. Although a few markers in the GAD2 gene
have P-values < 0.05 for their associations with TOLMX and WDSFS, they became non-
significant after adjusting for false discoveries, which may result from small effect size of those
markers or insufficient power to detect their effects with the current sample size of cases.
3.3. Linkage disequilibrium structure
For GAD1, two blocks were defined consisting of 2 and 5 markers, respectively. However, LD
between these two blocks is strong and yields a highly correlated haplotype distribution for the
common haplotypes. The most common haplotype in block 1 (frequency 42.8%) occurs with
the most common haplotype in block 2 (43.1%); the second and third most common haplotypes
in block 1 are similarly related to the corresponding haplotypes in block 2. The one-to-one
correspondence of the three common haplotypes results in a high correlation of 0.84 between
the two blocks. Therefore, we collapsed the two blocks together, forming a long haplotype
block with seven markers. For GAD2, LD was extremely high among 9 out of 11 genotyped
markers, with a mean pair-wise D′ of 0.983 (D′ estimates for adjacent SNPs were greater than
0.95 for 97% of the comparisons). We used Tagger with r2 of 0.8 and MAF of 0.2 (de Bakker
et al., 2005) to select the minimum numbers of markers to capture maximum haplotype
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variation within blocks for the GAD1 and GAD2 genes. Consequently, four (rs2241165,
rs3828275, rs2058725, rs701492) and two (rs2839677, rs7900976) tagging SNPs were used
for haplotype analyses in GAD1 and GAD2, respectively.
3.4. Haplotypic association
We examined association of haplotypes using only the Tagger-defined tagging SNPs (Table
4). For GAD1, the four SNPs form seven haplotypes with frequency greater than 0.01. Three
common haplotypes together represent 90% of haplotypes observed. A significant association
was found for ISENS with haplotype 2111 (frequency = 0.01) in females, which consisted of
a minor allele of marker rs2241165 and common alleles of rs3828275, rs2058725, and
rs701492. Again, the negative regression coefficient of this haplotype with ISENS and
TOLMX indicated fewer drinks needed to feel subjective effects, in both drinking initiation
and heaviest drinking periods, among individuals with this haplotype. In males, the 1121
haplotype (frequency = 0.02) showed association with WDSFS (FDR adjusted P < 0.05) with
a negative regression coefficient, indicating a less severe withdrawal syndrome among
individuals with this haplotype. However, both associated haplotypes had small frequency
(representing 13–25 chromosomes each among our samples), thus the significant haplotypic
findings and their true contributions should be taken in caution and larger study is required to
confirm these findings. For GAD2, none of the three common haplotypes were significantly
associated with alcohol-related traits using criteria of FDR adjusted P < 0.05.
4. Discussion
Several lines of animal and human research have linked the GABAergic neurotransmitter
system to various aspects of addictive behaviors and pharmacotherapies (Ikemoto, 2005;
Kalivas, 2007; Koob, 2004; Roberts, 2005). The GAD genes are of special interests because
GAD is the rate-limiting enzyme for synthesis of GABA in the brain. Animal QTL studies of
alcohol-related phenotypes have consistently identified murine genomic regions which
mapped to GABA receptor and the GAD genes (Buck and Finn, 2001; Crabbe et al., 1999,
2006). Past rodent studies have also produced valuable information for understanding genetic
effects on specific components of alcohol-related phenotypes relative to the heterogeneous
performance of AD clinical diagnosis in humans. The present study examined the association
between GAD genes with AD as well as relevant alcohol-related phenotypes in humans.
Our main association findings were for the quantitative alcohol-related traits, initial sensitivity
to alcohol and age at onset of AD. Several markers in GAD1 showed significant associations,
and the effects were stronger in males than in females. For the three markers in GAD1 (Table
3) that exhibited significant associations with initial sensitivity to alcohol for which the
common allele is risk allele, we calculated genotype means of alcohol intake to reach subjective
effect at the time of initial use. Individuals with homozygote common vs. rare alleles required
mean drinks of 6.9 vs. 5.2 in males, and 5.6 vs. 4.6 in females to feel ethanol effects. Initial
sensitivity to alcohol may be more related to acute response to ethanol. Animal studies have
shown that acute response to ethanol results in increase of GABA release in the brain and
requires more GAD to transfer glutamic acid to produce GABA. For age at onset of AD, marker
rs1978340 in GAD1 gene exhibited significant association. Males with homozygote common
vs. rare alleles had mean onset age of 26.3 vs. 22.6 years, while onset age was not differed by
genotypes in females.
Contrary to our expectations, neither the GAD1 nor the GAD2 genes exhibited significant
associations with AD after the significance level was adjusted to control for false discoveries.
Other than two previous reports for the associations of GAD1 and GAD2 in Han Taiwanese
men (Loh et al., 2006) and GAD2 in Russian men (Lappalainen et al., 2007), the current study
is the first to include both male and female subjects with relatively larger sample size to examine
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the associations of AD and several relevant alcohol-related traits with the two GAD genes in
a sample from Ireland that is culturally and genetically homogeneous. In different populations,
allele or genotype frequencies may exhibit variation across ethnic groups that will influence
genetic associations. For GAD1, one marker (rs701492) in Loh et al. (2006) report was also
genotyped in our sample with very similar MAF in both studies (In Loh's Taiwanese and our
Irish samples: case = 0.29, control = 0.32). However, this marker exhibited genotypic
difference (P = 0.01) between their male AD cases and controls, but did not show such
difference (P = 0.42) in our study. For GAD2, marker rs2839670 which is located near 5′ of
the gene was genotyped in all three studies with varying MAF distribution across populations
(Among AD cases, MAF were 0.12, 0.18, 0.28 for Russian, Irish, Taiwanese samples; among
controls, MAF were 0.19, 0.20, 0.23 for the three populations). This marker showed significant
genotypic association in the Russian sample (P = 0.01) but not in the Irish and Taiwanese
samples. With the sample size in the current study, in most of the situations we shall have
power of 0.8 to detect an effect size (such as odds ratio) greater than 1.3. Therefore, the negative
association findings with AD diagnosis are unlikely due to inadequate power if loci have
notable effects on AD. Overall, although we did not observe direct effects of single markers
in the GAD genes on the risk to develop AD, they may have impact via their influences on
initial sensitivity to ethanol and the onset age of developing AD.
Several markers exhibited gender specific association effects. For instance, markers rs1978340
& rs3791878 (at 5′ near GAD1 gene) showed effects in males only with minor allele as the risk
allele (has early AD age-at-onset), while the same markers showed no such effects in females.
Females with minor allele had later age-at-onset of AD (Table 3, males and females have
coefficients in opposite directions) though not statistically significant. Similarly, marker
rs2839673, which is a coding SNP (in exon 6 of GAD2) was modestly associated with
withdrawal severity showing opposite direction of coefficients in females and males.
Haplotypic analyses results (Table 4) showed similar patterns of bi-direction effects by genders
and the associations mainly restricted to one gender. For instance, haplotype 2111 in GAD1
exhibited strong association with initial sensitivity to ethanol and tolerance/maximum drinking
only in females, and haplotype 1121 exhibited strong association with withdrawal severity only
in males. Because both haplotypes are not common haplotypes (frequency around 1–2%, which
represents 13–25 chromosomes in our sample), we did not test for gender interactions directly
in the present study. The real contribution of rare haplotypes in genetic association studies and
possible gender differences need to be further tested and confirmed in larger studies.
Many reasons can contribute to gender differences, such as hormone levels (e.g. estrogen,
progesterone), innate differences in neuronal system adaptations, and pharmacokinetics of
abused drugs in body (Becker, 1999; Carroll et al., 2004; Russo et al., 2003). Significant gender
differences were reported in self-administration of drugs during pharmacological treatment
using GABA receptor agonist in rats and kappa opioid receptor agonist in monkeys, which
suggest sex-related differences in neurotransmission system. Rodent studies have shown that
gender impacts on adaptations in GABA receptors. Female ethanol withdrawn rats showed
greater sensitization to endogenous neuroactive steroids, which have selective effects at GABA
and N-methyl-D-aspartate receptors (Devaud et al., 1998). In addition, GABAAα4 subunit
expression in hippocampus and cerebral cortex were significantly increased in males, but not
in females after chronic ethanol administration (Devaud and Alele, 2004). Effects of ethanol
withdrawal on gene expression were also different by gender, thus female rats tend to have
higher GAD1 level than males in the hippocampus and cerebral cortex, while male rats
exhibited higher level of GAD2 than females in both brain areas (Alele and Devaud, 2005).
Overall, gender differences may occur at many levels of alcohol addiction, from observed
behavioral changes, neuroadaptive functions, to underlying genetic variations. Evaluation of
gender specific effects in physiological and genetic studies may assist in understanding of
underlying mechanisms of compulsive addicted behaviors and have clinical implications on
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the influences of drug treatment response among addictive individuals. Potential gender
differences in GAD genetic associations we reported may concert with behavioral and gene
expression findings reported in the literature, although the underlying physiological
mechanism requires further study.
This study has some limitations. First, alcohol-related traits were measured only among cases
but not controls. This is not a problem for age-at-onset of AD and withdrawal, which are only
meaningful in AD cases. For initial sensitivity, without information from a general population
sample, our association findings have limited generalizability. It would be ideal to test for gene
effects for initial sensitivity on alcohol use in the general population. Second, our association
results do not directly address whether there is functional variation in the GAD genes that is
related to expression level change of GAD. Addressing this question requires a different study
design. Third, although the LD patterns of both GAD genes are compatible with Hapmap CEPH
population data, it remains possible that we do not have a full coverage set of SNPs to detect
potential association in these genes, especially rare functional polymorphisms. Finally,
whereas GAD genes are our main focus in the present study, we did not include genes encoding
for the downstream product GABA, and several GABA receptor genes. In future studies we
plan to examine the roles of GABA receptor genes and to conduct pathway analysis for genes
involved in the inhibitory neurotransmission system.
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The LD plot (D′) and SNPs location within each GAD gene. Haplotype blocks were defined
using the default method in Haploview by Gabriel et al. (2002).
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